Home World News L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published by the Lancet

L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published by the Lancet

Ditulis Oleh ProArt By Satyam October 10, 2021

Advertisemen

submitted by /u/MedicalPrize
[link] [comments]

from World News https://ift.tt/3Dwf8wl
via /u/MedicalPrize

Advertisemen

L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published by the Lancet

Add Comments